These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Modulation of intracellular calcium by potassium channel openers in vascular muscle. Erne P, Hermsmeyer K. Naunyn Schmiedebergs Arch Pharmacol; 1991 Dec; 344(6):706-15. PubMed ID: 1775202 [Abstract] [Full Text] [Related]
6. Characterization of the vasodilatation by the K+ channel openers: cromakalim and pinacidil. Rhim BY, Lee WS, Hong KW. Jpn J Pharmacol; 1992 Dec; 58 Suppl 2():335P. PubMed ID: 1507584 [No Abstract] [Full Text] [Related]
9. Cerebral vascular smooth muscle potassium channels and their possible role in the management of vasospasm. Zhang H, Cook D. Pharmacol Toxicol; 1994 Dec; 75(6):327-36. PubMed ID: 7899253 [Abstract] [Full Text] [Related]
10. K(+)-channel openers for relaxation of isolated penile erectile tissue from rabbit. Holmquist F, Andersson KE, Fovaeus M, Hedlund H. J Urol; 1990 Jul; 144(1):146-51. PubMed ID: 2359166 [Abstract] [Full Text] [Related]
11. Cardioprotective profile of the cardiac-selective ATP-sensitive potassium channel opener BMS-180448. Grover GJ, McCullough JR, D'Alonzo AJ, Sargent CA, Atwal KS. J Cardiovasc Pharmacol; 1995 Jan; 25(1):40-50. PubMed ID: 7723352 [Abstract] [Full Text] [Related]
12. Comparative effects of K+ channel blockade on the vasorelaxant activity of cromakalim, pinacidil and nicorandil. Wilson C, Coldwell MC, Howlett DR, Cooper SM, Hamilton TC. Eur J Pharmacol; 1988 Aug 02; 152(3):331-9. PubMed ID: 2851450 [Abstract] [Full Text] [Related]
13. Inhibition of contractile responses of human myometrium and intramyometrial arteries by potassium channel openers. Kostrzewska A, Laudański T, Batra S. Acta Obstet Gynecol Scand; 1996 Nov 02; 75(10):886-91. PubMed ID: 9003087 [Abstract] [Full Text] [Related]
14. Comparison of effects of cromakalim and pinacidil on mechanical activity and 86Rb efflux in dog coronary arteries. Masuzawa K, Asano M, Matsuda T, Imaizumi Y, Watanabe M. J Pharmacol Exp Ther; 1990 May 02; 253(2):586-93. PubMed ID: 2160002 [Abstract] [Full Text] [Related]
16. [Ca-antagonist, K-channel-opener in the treatment of patients with congestive heart failure]. Satoh K. Nihon Rinsho; 1993 May 02; 51(5):1293-8. PubMed ID: 8331797 [Abstract] [Full Text] [Related]
17. KATP channel modulators increase survival rate during coronary occlusion-reperfusion in anaesthetized rats. Baczkó I, Leprán I, Papp JG. Eur J Pharmacol; 1997 Apr 11; 324(1):77-83. PubMed ID: 9137916 [Abstract] [Full Text] [Related]
18. [Advance in pharmacology of potassium channels in cardiovascular system and their clinical use]. Wu Y, Fang D. Zhonghua Yi Xue Za Zhi; 1992 Mar 11; 72(3):180-3. PubMed ID: 1319810 [No Abstract] [Full Text] [Related]
19. Effect of cromakalim and pinacidil on 86Rb efflux from guinea pig urinary bladder smooth muscle. Trivedi S, Stetz S, Levin R, Li J, Kau S. Pharmacology; 1994 Sep 11; 49(3):159-66. PubMed ID: 7972330 [Abstract] [Full Text] [Related]
20. K+ channel openers delay intestinal transit and have antidiarrheal activity. Poggioli R, Benelli A, Arletti R, Cavazzuti E, Bertolini A. Eur J Pharmacol; 1995 Dec 12; 287(2):207-9. PubMed ID: 8749038 [Abstract] [Full Text] [Related] Page: [Next] [New Search]